Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Efficacy and Safety of Cilostazol in the Prevention of Ischemic Vascular Events in Diabetic Patients With Symptomatic Peripheral Artery Disease.

NCT02983214 is registered in ClinicalTrials.gov with University of Ioannina as lead sponsor.

NCT NCT02983214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02983214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Efficacy and Safety of Cilostazol in the Prevention of Ischemic Vascular Events in Diabetic Patients With Symptomatic Peripheral Artery Disease.
Lead sponsor
University of Ioannina
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2016
Completion date
October 31, 2019
Enrollment
826 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, ischemic stroke, peripheral artery disease